CAT vs RIGL · P/E 48, rev $20.54B vs P/E 9.1, rev $179.3M
Caterpillar Inc (CAT) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the CAT and RIGL stock pages for the full models.
Not investment advice.